Floatz logo

FENTANYL

Mucositis

INSYS Therapeutics IncSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Mucositis cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Swedish Orphan Biovitrum
Phase 3BB
CALCIUM PHOSPHATE
Children's Oncology Group
Phase 3BB
Fentanyl Sublingual Spray
INSYS Therapeutics Inc
Phase 3BB
Palifermin
Barbara Ann Karmanos Cancer Institute
Phase 3BB
Calcium folinate pentahydrate
Tanta University
Phase 1/2B

View all 17 →

Same molecule, other indications

FENTANYL is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →